In 3/4 children with genetically unclassified AML, FLT3-ITD (n = 2) or WT1m (n = 1) were used as MRD targets (with detection sensitivity of at least 10−4), with the awareness of their potential subclonality. Here, FLT3 is linked to acute myeloid leukemia.